Gilead Sciences Inc. Stock Rises 3.7%, Outperforms Peers

Dow Jones01-24

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Gilead Sciences Inc. advanced 3.7% to $135.93 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,915.61 and the Dow Jones Industrial Average falling 0.6% to 49,098.71.

This was the stock's third consecutive day of gains.

Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $133.10, which the company reached on January 22nd.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $220.14, Pfizer Inc. fell 0.1% to $25.65, and Abbott Laboratories fell 1.10% to $107.42.

Trading volume totaled 13.2 million, compared to the 50-day average of 6.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 23, 2026 16:34 ET (21:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605054283?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-24 05:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605054283","market":"hk","top_or_hot":-1,"title":"Gilead Sciences Inc. Stock Rises 3.7%, Outperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. advanced 3.7% to $135.93 on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index remaining mostly unchanged at 6,915.61 and the Dow Jones Industrial Average falling 0.6% to 49,098.71. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $133.10, which the company reached on January 22nd. \n</p>\n<p>\n     The stock outperformed some of its peers, as Johnson &amp; Johnson rose 0.8% to $220.14, Pfizer Inc. fell 0.1% to $25.65, and Abbott Laboratories fell 1.10% to $107.42. \n</p>\n<p>\n     Trading volume totaled 13.2 million, compared to the 50-day average of 6.9 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2026 16:34 ET (21:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gilead Sciences Inc. Stock Rises 3.7%, Outperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGilead Sciences Inc. Stock Rises 3.7%, Outperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-24 05:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. advanced 3.7% to $135.93 on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index remaining mostly unchanged at 6,915.61 and the Dow Jones Industrial Average falling 0.6% to 49,098.71. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $133.10, which the company reached on January 22nd. \n</p>\n<p>\n     The stock outperformed some of its peers, as Johnson &amp; Johnson rose 0.8% to $220.14, Pfizer Inc. fell 0.1% to $25.65, and Abbott Laboratories fell 1.10% to $107.42. \n</p>\n<p>\n     Trading volume totaled 13.2 million, compared to the 50-day average of 6.9 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 23, 2026 16:34 ET (21:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GILD","symbol_name":"吉利德科学","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2605054283","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605054283","pubTimestamp":1769204040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Gilead Sciences Inc. advanced 3.7% to $135.93 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,915.61 and the Dow Jones Industrial Average falling 0.6% to 49,098.71.This was the stock's third consecutive day of gains.Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $133.10, which the company reached on January 22nd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $220.14, Pfizer Inc. fell 0.1% to $25.65, and Abbott Laboratories fell 1.10% to $107.42.Trading volume totaled 13.2 million, compared to the 50-day average of 6.9 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"GILD":"吉利德科学"},"translate_title":"吉利德科学股价上涨3.7%，跑赢同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GILD":1.5},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Gilead Sciences Inc. advanced 3.7% to $135.93 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,915.61 and the Dow Jones Industrial Average falling 0.6% to 49,098.71. \n\n\n     This was the stock's third consecutive day of gains. \n\n\n     Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $133.10, which the company reached on January 22nd. \n\n\n     The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $220.14, Pfizer Inc. fell 0.1% to $25.65, and Abbott Laboratories fell 1.10% to $107.42. \n\n\n     Trading volume totaled 13.2 million, compared to the 50-day average of 6.9 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2026 16:34 ET (21:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605054283","isCrawlerRequest":true}